{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:37:39Z","timestamp":1788845859149,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> The care of patients with multiple sclerosis (MS) calls for a lifelong guidance and treatment and results in a high resource utilization. Therefore, strategies for the assessment and improvement of the care process are crucial. Quality indicators have become a widely used instrument to determine quality in many areas of the healthcare system. The currently available sets of indicators for the quality of MS care are summarized in this review.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A literature search was conducted for reports that include statements on quality indicators for the care of people with MS. For the determination of the strength of the underlying evidence of the identified publications appropriate criteria of the PRISMA and AGREE-Statements were used. A further prioritization of the eligible indicators was based on the internal grading by the initial authors.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Of the 465 included records in the search, 6 sources were finally identified, 3 demonstrating a high and the others a medium strength of evidence. In total, these six reports described 226 quality indicators for the treatment of MS. Of them, 147 were further included in the assessment due to the scope of this article. Among the 101 indicators that originated from reports with a high strength of evidence, 6 also had a high initial internal grading. These six identified quality indicators describe five important characteristics of a high-quality care of MS.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The search led to a scientifically evident set of six quality indicators for the assessment of care for patients with MS. These should be seen as starting points in the development of comprehensive sets of quality indicators in MS that addresses the individual objective of their use.<\/jats:p>","DOI":"10.3389\/fneur.2021.708723","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T04:21:00Z","timestamp":1628137260000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Quality of Care for Patients With Multiple Sclerosis\u2014A Review of Existing Quality Indicators"],"prefix":"10.3389","volume":"12","author":[{"given":"Anna Kristina","family":"Kraft","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"B1","unstructured":"Handbook for National Quality Policy and Strategy: A Practical Approach for Developing Policy and Strategy to Improve Quality of Care2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1001\/jama.260.12.1743","article-title":"The quality of care. How can it be assessed?","volume":"260","author":"Donabedian","year":"1988","journal-title":"JAMA."},{"key":"B3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/intqhc\/mzg081","article-title":"Defining and classifying clinical indicators for quality improvement","volume":"15","author":"Mainz","year":"2003","journal-title":"Int J Qual Health Care."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1161\/01.STR.0000241086.92084.c0","article-title":"Development and implementation of evidence-based indicators for measuring quality of acute stroke care: the Quality Indicator Board of the German Stroke Registers Study Group (ADSR)","volume":"37","author":"Heuschmann","year":"2006","journal-title":"Stroke."},{"key":"B5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/anae.14861","article-title":"The identification of key indicators to drive quality improvement in obstetric anaesthesia: results of the Obstetric Anaesthetists' Association\/National Perinatal Epidemiology Unit collaborative Delphi project","volume":"75","author":"Bamber","year":"2020","journal-title":"Anaesthesia."},{"key":"B6","volume-title":"Versorgungsprofile der Multiplen Sklerose im vertrags\u00e4rztlichen Sektor","author":"Holstiege","year":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"i1152","DOI":"10.1136\/bmj.i1152","article-title":"The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines","volume":"352","author":"Brouwers","year":"2016","journal-title":"BMJ."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1352458518809326","DOI":"10.1177\/1352458518809326","article-title":"International consensus on quality standards for brain health-focused care in multiple sclerosis","author":"Hobart","year":"2018","journal-title":"Mult Scler."},{"key":"B10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1177\/1352458510372394","article-title":"Quality indicators for multiple sclerosis","volume":"16","author":"Cheng","year":"2010","journal-title":"Mult Scler."},{"key":"B11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1212\/WNL.0000000000005347","article-title":"Practice guideline recommendations summary: disease modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1212\/WNL.0000000000001965","article-title":"Quality improvement in neurology: multiple sclerosis quality measures: executive summary","volume":"85","author":"Rae-Grant","year":"2015","journal-title":"Neurology."},{"key":"B13","unstructured":"Multiple Sclerosis in Adults: Management (Clinical Guideline 186)2014"},{"key":"B14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler."},{"key":"B15","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult Scler Relat Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1212\/WNL.0000000000005345","article-title":"Comprehensive systematic review summary: disease-modifying therapies for adults with multiple sclerosis: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology","volume":"90","author":"Rae-Grant","year":"2018","journal-title":"Neurology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"CD012732","DOI":"10.1002\/14651858.CD012732.pub2","article-title":"Rehabilitation for people with multiple sclerosis: an overview of cochrane reviews","volume":"1","author":"Amatya","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1177\/1352458511403643","article-title":"Multiple sclerosis, from referral to confirmed diagnosis: an audit of clinical practice","volume":"17","author":"Kelly","year":"2011","journal-title":"Mult Scler."},{"key":"B19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.7224\/1537-2073.2014-097","article-title":"Assessing four quality indicators for multiple sclerosis management through patient-reported data","volume":"18","author":"Shoemaker","year":"2016","journal-title":"Int J MS Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/1352458513495937","article-title":"Constructing an adaptive care model for the management of disease related symptoms throughout the course of multiple sclerosis-performance improvement CME","volume":"20","author":"Miller","year":"2014","journal-title":"Mult Scler."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.708723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T04:21:06Z","timestamp":1628137266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.708723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":20,"alternative-id":["10.3389\/fneur.2021.708723"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.708723","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"article-number":"708723"}}